Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1119]
News [2438]
Articles [146]
Editorials [8]
Conferences [102]
elearning [12]
New study asks patients preference on kidney cancer treatment
Dr Bernard Escudier - Institut Gustave Roussy, Paris, France
New study asks patients preference on kidney cancer treatment ( Dr Bernard Escudier - Institut Gustave Roussy, Paris, France )
2 Jun 2012
Current treatment practices in metastatic castration resistant prostate cancer
Prof Joachim Bellmunt, Prof Nicolas Mottet, Prof Noel Clarke, Prof Alfredo...
Current treatment practices in metastatic castration resistant prostate cancer ( Prof Joachim Bellmunt, Prof Nicolas Mottet, Prof Noel Clarke, Prof Alfredo Berruti )
22 May 2012
Evidence for TORC1 activation marker as a predictive factor for everolimus...
Dr Thomas Bachelot - Centre Leon Berard, Lyon, France
Evidence for TORC1 activation marker as a predictive factor for everolimus efficacy in metastatic breast cancer ( Dr Thomas Bachelot - Centre Leon Berard, Lyon, France )
17 May 2012
Long term survival with testicular cancer
Sophie Bunskoek – University Medical Center Gronigen, The Netherlands
Long term survival with testicular cancer ( Sophie Bunskoek – University Medical Center Gronigen, The Netherlands )
11 May 2012
Supportive care for men with prostate cancer
Jane Cockle-Hearne – University of Surrey, Guildford, UK
Supportive care for men with prostate cancer ( Jane Cockle-Hearne – University of Surrey, Guildford, UK )
10 May 2012
Non invasive biomarkers for prostate cancer
Dr David Ulmert - Memorial Sloan-Kettering Cancer Center, New York, USA; Dr...
Non invasive biomarkers for prostate cancer ( Dr David Ulmert - Memorial Sloan-Kettering Cancer Center, New York, USA; Dr Michael Evans - Memorial Sloan-Kettering Cancer Center, New York, USA )
17 Apr 2012
Metformin to slow prostate cancer growth
Dr Anthony Joshua - Princess Margaret Hospital, Toronto, Canada
Metformin to slow prostate cancer growth ( Dr Anthony Joshua - Princess Margaret Hospital, Toronto, Canada )
13 Apr 2012
Hypoxia influenced tumour behaviour in prostate cancer
Dr Michael Milosevic - University of Toronto, Ontario, Canada
Hypoxia influenced tumour behaviour in prostate cancer ( Dr Michael Milosevic - University of Toronto, Ontario, Canada )
13 Apr 2012
Biomarker identified in relation to pazopanib in refractory urothelial cancer
Dr Andrea Necchi - National Cancer Institute of Milan, Italy
Biomarker identified in relation to pazopanib in refractory urothelial cancer ( Dr Andrea Necchi - National Cancer Institute of Milan, Italy )
13 Apr 2012
Noninvasive imaging markers in prostate cancer
Dr Michael Evans - Memorial Sloan-Kettering Cancer Center, New York, USA
Noninvasive imaging markers in prostate cancer ( Dr Michael Evans - Memorial Sloan-Kettering Cancer Center, New York, USA )
13 Apr 2012
Effects of vitamin D on prostate cancer
Prof Reinhold Vieth - University of Toronto, Ontario, Canada
Effects of vitamin D on prostate cancer ( Prof Reinhold Vieth - University of Toronto, Ontario, Canada )
13 Apr 2012
Evolving treatment options in castration-resistant prostate cancer
Prof Gordon Mcvie, Prof Johann De Bono, Prof Bertrand Tombal, Prof Juergen...
Evolving treatment options in castration-resistant prostate cancer ( Prof Gordon Mcvie, Prof Johann De Bono, Prof Bertrand Tombal, Prof Juergen Gschwend, Dr Maria De Santis )
3 Feb 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation